EverImmune provides therapeutic tools related to cancer.
EverImmune has raised $3.7M in total funding. The most recent round was Debt Financing. The last funding was announced in September 2023.
EverImmune's investors include Bpifrance.
EverImmune is headquartered in Villejuif, France.
EverImmune provides therapeutic tools related to cancer.
EverImmune is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EverImmune — Funding & Investors." VCBacked, September 19, 2023, https://www.vcbacked.co/company/everimmune. Accessed October 19, 2026.
VCBacked. (2023). EverImmune — Funding & Investors. Retrieved October 19, 2026, from https://www.vcbacked.co/company/everimmune
{{cite web |title=EverImmune — Funding & Investors |url=https://www.vcbacked.co/company/everimmune |website=VCBacked |access-date=October 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated